您的位置: 首页 > 农业专利 > 详情页

crystalline form of n- [1- (5-cyano-pyridin-2-ylmethyl) -1h-pyrazol-3-yl] -2- [4- (1-trifluoromethyl-cyclopropyl) -phenyl] -acetamide, and, composition pharmaceutical company.
专利权人:
IDORSIA PHARMACEUTICALS LTD
发明人:
BIBIA HEIDMANN,MARKUS VON RAUMER
申请号:
BR112020000099
公开号:
BR112020000099A2
申请日:
2018.07.04
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
the present invention relates to crystalline forms of n- [1- (5-cyano-pyridin-2-ylmethyl) -1h-pyrazol-3-yl] -2- [4- (1-trifluoromethyl-cyclopropyl) -phenyl ] -acetamide, pharmaceutical compositions comprising said crystalline forms and their use as type t calcium channel blockers in the treatment or prevention of diseases or disorders in which type t calcium channels are involved.a presente invenção refere-se a formas cristalinas de n-[1-(5-ciano-piridin-2-ilmetil)-1h-pirazol-3-il]-2-[4-(1-trifluorometil-ciclopropil)-fenil]-acetamida, composições farmacêuticas compreendendo as ditas formas cristalinas e seu uso como bloqueadores de canal de cálcio tipo t no tratamento ou na prevenção de doenças ou distúrbios em que canais de cálcio tipo t estão envolvidos.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充